"Designing Growth Strategies is in our DNA"
Asia Pacific is the third largest region in the global dry eye syndrome market. It is projected to grow at a CAGR of 9.3% during the forecast period. The global dry eye syndrome market is projected to grow from USD 6.61 billion in 2022 to USD 11.26 billion by 2030.
The growing adoption of eye care products for the treatment of dry eye syndrome has led market players in the region to emphasize getting regulatory approvals to expand their product presence in Asian countries. For instance, in October 2021, Ikervis, a product of Santen Pharmaceutical Co., Ltd. was listed on Australia's Pharmaceutical Benefits Scheme (PBS). The company received approval for Ikervis in December 2020 from the Therapeutics Goods Administration (TGA) to commercialize the product in Australia through Seqirus. Similar efforts from leading players will accelerate the Asia Pacific dry eye syndrome treatment market growth during the forecast duration.
Our report on the Asia Pacific dry eye syndrome market covers the following countries/regions - Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific.
Introduction of Innovative Campaigns to Increase Product Adoption Rate
One of the prevailing trends observed in the market is the rising initiatives of market players to increase awareness of this condition and promote their product offerings as a therapeutic measure through launching innovative campaigns. In July 2021, Sun Pharmaceutical Industries Limited, an India based company, launched an unbranded video campaign called “Dry Eye Gets Personal”. Furthermore, government authorities of various Asian countries are also organizing events to increase awareness of the diagnosis and treatment of this condition which is anticipated to offer growth opportunities for market players to introduce novel products in the coming years. Such trends will contribute to the increase of the market size in the forecast period.
Preference for Over the Counter Drugs in Asian Countries to Drive the Market Growth
One of the critical factors driving the market growth in the region is the growing preference for Over-The-Counter (OTC) drugs especially artificial tears for the treatment of dry eye syndrome. Over-the-counter artificial tears historically have been the first line of treatment for dry eye syndrome and dry eye‐related conditions. Moreover, ocular lubricants are designed to support the quality and quantity of tear film and are the first-line treatment for this condition in many Asian countries such as China, South Korea, Japan, and Thailand.
Request a Free sample to learn more about this report.
Low Priority Given to Ocular Health May Restrict the Market Growth
One of the leading factors responsible for the growing prevalence of this condition is the ignorant attitude of the general population toward ocular health. One of the major factors delaying timely treatment is the lack of awareness of eye conditions which can be treated or corrected easily with proper diagnosis and medications such as anti-inflammatory drugs. In Asian countries such as India, people do not visit ophthalmologists on a regular basis unless there is a major symptomatic condition observed. Hence, the prevalence of such ocular conditions is also increasing due to long-term exposure to digital devices.
In terms of the competitive landscape, some of the key players dominating in terms of the Asia Pacific dry eye syndrome market share are AbbVie, Inc., Alcon, Novartis AG, and Santen Pharmaceutical Co., Ltd. The companies are focused on strengthening their market position through active investment in R&D by getting approvals in various Asian countries, especially Santen.
Other players include Bausch & Lomb Pvt. Ltd. and Sun Pharmaceutical Industries Ltd., who are focusing on undertaking research collaborations and expanding product presence across the region. Some other major players are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Vision Care, Inc., Sentiss Pharma Pvt. Ltd., and others. These companies are focused on expanding their product presence through various campaigns to increase their product adoption rate and market share in Asia Pacific.
To gain extensive insights into the market, Request for Customization
The market research report provides qualitative and quantitative insights on the market and a detailed analysis of the market size & growth rate for all possible segments in the market. Along with the market forecast, the report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights presented in the report are prevalence of dry eye syndrome, by key countries, trend analysis, key industry developments, new product launches, reimbursement policies, regulatory scenario, healthcare industry overview, and the impact of COVID-19 on the market.
CAGR of 9.3% from 2023 to 2030
Value (USD billion)
By Product, Distribution Channel, and Country/Sub-Region
By Distribution Channel
By Country/ Sub-Region
Growing at a CAGR of 9.3%, the market will exhibit steady growth in the forecast period (2023-2030).
The increasing prevalence of comorbidities such as autoimmune disorders leading to dry disease syndrome coupled with higher preference of patients toward OTC drugs across the region are some of the major factors driving the growth of the market.
AbbVie, Inc., Alcon, Novartis AG, and Santen Pharmaceutical Co., Ltd. are the major \ players in the Asia Pacific market.
Japan dominated the market in 2022.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry